Peru reports first sexually transmitted Zika case
Peru has suffered its first case of sexually transmitted, locally contracted Zika virus, authorities said Saturday.
Apr 16, 2016
Archive: 16/04/2016
Sarcopenia, which affects up to 20 percent of European seniors, may increase 63 percent by 2045
Today, at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. researchers from the University of Liège, Belgium presented a study that reveals the enormous and growing burden of sarcopenia in ...
Apr 16, 2016
Farmers are not just the backbone of a nation, they may have stronger hips too
A team of UK and Swedish researchers has released the findings of a new study which assessed the hip fracture risk of farmers in Sweden.
Apr 16, 2016
Study shows hip fracture risk rises in the 10 years after total knee replacement
Researchers from the Sahlgrenska Academy in Molndal, Sweden have published preliminary results of a fracture risk study, which was based on analysis of medical records from 1987 to 2002 covering the entire Swedish population ...
Apr 16, 2016
Study supports cardiovascular safety of calcium and vitamin D supplementation
UK researchers have presented a new study that supports the cardiovascular safety of calcium and vitamin D supplementation. The study was based on analysis of the UK Biobank, a very large study comprising 502,664 men and ...
Apr 16, 2016
Phase 2 data show treatment efficacy in 'difficult-to-cure' hepatitis C patients
A Hepatitis C (HCV) drug currently under investigation, ABT-493 and ABT-530, which is an all-oral once-daily antiviral treatment, helped HCV genotype 3 patients with heavily scarred livers and no previous treatment history ...
Apr 16, 2016
Scientists find a way to cure hepatitis C with 6 weeks of treatment
A pilot study presented today found that all patients with acute HCV who were treated with a direct-acting antiviral treatment over a 'short-duration' of six weeks had undetectable HCV after a 12 week follow-up. The investigator-initiated ...
Apr 16, 2016
Potential first-in-class treatment is well-tolerated in patients with chronic hepatitis B
New data presented today confirms that a novel first-in-class treatment for Hepatitis B, called NVR 3-778, is well-tolerated and can reduce levels of the virus' genetic material in the body when combined with pegylated interferon ...
Apr 16, 2016
New study demonstrates efficacy of all-oral treatment regimens in adolescents with hepatitis C virus
Adolescents with Hepatitis C (HCV) could benefit from a combination of direct-acting antivirals, according to new data presented today at The International Liver Congress 2016 in Barcelona, Spain. The study demonstrated that ...
Apr 16, 2016
